<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 08/26/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 08/26/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Lyndall C Gibbs</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">March 6, 1958 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Not Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>10426 BRAEMER ST<br/>CROSBY, TX 77532-7009, US<br/><br/>Primary Home Phone:  559-309-9335<br/>Mobile Phone:  832-580-1775<br/>Email:  karol9140@yahoo.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">10361 2.16.840.1.113883.4.391.331188<br/>10361 2.16.840.1.113883.4.391.331188.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">7413c0ce-ee99-46b4-9b02-0e81dbbeb49c 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">September 6, 2024, 13:44:16, EST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Faiza Tahir</td></tr><tr><td class="td_header_role_value internal_format">6051 garth road<br/>suite 1100<br/>Baytown, TX 77521, US<br/><br/>Tel:  832-400-9249<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">40558 2.16.840.1.113883.4.391.331188</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From August 26, 2024, 14:45:00   to August 26, 2024, 15:00:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.331188</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Faiza Tahir</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">6051 garth road<br/>suite 1100<br/>Baytown, TX 77521, US<br/><br/>Tel:  832-400-9249<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">Lyndall Gibbs<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  559-309-9335<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Faiza Tahir signed at August 26, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">6051 garth road<br/>suite 1100<br/>Baytown, TX 77521, US<br/><br/>Tel:  832-400-9249<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">Tamcare</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">6051 garth road<br/>suite 1100<br/>Baytown, TX 77521, US<br/><br/>Tel:  832-400-9249<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Problems</a></li><li><a href="#id6">Vital Signs</a></li><li><a href="#id7">Encounters</a></li><li><a href="#id8">Assessments</a></li><li><a href="#id9">Plan Of Treatment</a></li><li><a href="#id10">Progress Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>2 month f/u</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Fluconazole 200 MG</td><td ID="instruction1">2 tablet Orally daily for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Omega 3</td><td ID="instruction2"/><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Cephalexin 500 MG</td><td ID="instruction3">1 capsule Orally Twice a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Cephalexin 500 MG</td><td ID="instruction4">1 capsule Orally Four times a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Aspirin</td><td ID="instruction5"/><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Lisinopril</td><td ID="instruction6"/><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Furosemide</td><td ID="instruction7"/><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Omeprazole</td><td ID="instruction8"/><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Ferrous Sulfate</td><td ID="instruction9"/><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Finasteride</td><td ID="instruction10"/><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Magnesium</td><td ID="instruction11"/><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">Potassimin</td><td ID="instruction12"/><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>711149003</td><td ID="Problem1">Antibiotic long-term use (V58.62)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>97.4 degrees Fahrenheit</td><td>08/26/2024</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>122 mm Hg</td><td>08/26/2024</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>73 mm Hg</td><td>08/26/2024</td></tr><tr><th ID="vital4">Heart Rate</th><td>70 /min</td><td>08/26/2024</td></tr><tr><th ID="vital5">Respiratory Rate</th><td>18 /min</td><td>08/26/2024</td></tr><tr><th ID="vital6">Oximetry</th><td>97 %</td><td>08/26/2024</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>Tamcare</td><td>6051 garth road suite 1100 Baytown, TX 77521</td><td>08/26/2024</td><td>Faiza Tahir</td><td>Histoplasmosis, unspecified B39.9 ; Chronic systolic (congestive) heart failure I50.22 ; HIV positive Z21 ; Endocarditis, valve unspecified I38 ; Chronic obstructive pulmonary disease, unspecified J44.9 ; Acute and subacute infective endocarditis I33.0 ; Antibiotic long-term use V58.62 ; Screening for STD (sexually transmitted disease) Z11.3 and HIV exposure Z20.6</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">08/26/2024</td><td>Histoplasmosis, unspecified (ICD-10 - B39.9)</td><td/><td><p>4/22/24</p><p>-Check serum histo Ag, CBC, CMP</p><p>-Cont fluconzole 400mg daily, anticipate ~12 month course total</p><p>-Cont cephalexcin for chronic supression indefinately</p><p>-RTC 2 months </p><p>6/25/24</p><p>cough improving </p><p>c/w Fluconazole 200 mg bid </p><p>check cbc,cmp,Rp,SED rate </p><p>check serum histoplasma antigen and antibody</p></td><td/></tr><tr><td ID="ref2">08/26/2024</td><td>Chronic systolic (congestive) heart failure (ICD-10 - I50.22)</td><td/><td/><td/></tr><tr><td ID="ref3">08/26/2024</td><td>HIV positive (ICD-10 - Z21)</td><td/><td> Tahir, Faiza 08/26/2024 03:47:42 PM &gt; Patient has HIV test antigen antibody positive on 6/25/2024Last HIV antigen and antibody was checked on August 2023 which was negative patient denies any new sexual encounters or new sexual partners he is married for the past 15 years wife according to him is HIV negativeCheck CD4 count, viral load, and repeat HIV antigen antibody testingPatient will return to clinic in 2 weeks</td><td/></tr><tr><td ID="ref4">08/26/2024</td><td>Endocarditis, valve unspecified (ICD-10 - I38)</td><td/><td/><td/></tr><tr><td ID="ref5">08/26/2024</td><td>Chronic obstructive pulmonary disease, unspecified (ICD-10 - J44.9)</td><td/><td/><td/></tr><tr><td ID="ref6">08/26/2024</td><td>Acute and subacute infective endocarditis (ICD-10 - I33.0)</td><td/><td/><td/></tr><tr><td ID="ref7">08/26/2024</td><td>Antibiotic long-term use (ICD9-CM - V58.62)</td><td/><td/><td/></tr><tr><td ID="ref8">08/26/2024</td><td>Screening for STD (sexually transmitted disease) (ICD-10 - Z11.3)</td><td/><td/><td/></tr><tr><td ID="ref9">08/26/2024</td><td>HIV exposure (ICD-10 - Z20.6)</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Fluconazole 200 MG</td><td>2 tablet Orally daily for 30 days</td><td/><td/><td/></tr><tr><td ID="potMeds2">Cephalexin 500 MG</td><td>1 capsule Orally Four times a day for 30 days</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Histoplasmosis, unspecified</td><td><p>4/22/24</p><p>-Check serum histo Ag, CBC, CMP</p><p>-Cont fluconzole 400mg daily, anticipate ~12 month course total</p><p>-Cont cephalexcin for chronic supression indefinately</p><p>-RTC 2 months </p><p>6/25/24</p><p>cough improving </p><p>c/w Fluconazole 200 mg bid </p><p>check cbc,cmp,Rp,SED rate </p><p>check serum histoplasma antigen and antibody</p></td></tr><tr><td ID="instructionpot2">HIV positive</td><td> Tahir, Faiza 08/26/2024 03:47:42 PM &gt; Patient has HIV test antigen antibody positive on 6/25/2024Last HIV antigen and antibody was checked on August 2023 which was negative patient denies any new sexual encounters or new sexual partners he is married for the past 15 years wife according to him is HIV negativeCheck CD4 count, viral load, and repeat HIV antigen antibody testingPatient will return to clinic in 2 weeks</td></tr></tbody></table><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">HIV 1/2 ANTIGEN/ANTIBODY,FOURTH GENERATION W/RFL (91431)</td><td>08/26/2024</td></tr><tr><td ID="pendingTest2">RPR (DX) W/REFL TITER AND CONFIRMATORY TESTING (36126)</td><td>08/26/2024</td></tr><tr><td ID="pendingTest3">LYMPHOCYTE SUBSET PANEL 5 (8360)</td><td>08/26/2024</td></tr><tr><td ID="pendingTest4">HIV 1 RNA, QL REAL TIME PCR (16185)</td><td>08/26/2024</td></tr><tr><td ID="pendingTest5">QUANTIFERON(R)-TB GOLD PLUS, 1 TUBE (36970)</td><td>08/26/2024</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 2 Weeks, Reason: follow up</td></tr><tr><td ID="futureAppt1">Provider Name:Faiza Tahir, 09/09/2024 10:00:00 AM, 6051 garth road, suite 1100, Baytown, TX, 77521, 832-400-9249</td></tr></tbody></table></div><h3><a name="id10" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>GIBBS, Lyndall C <span class="bold">DOB:</span> 03/06/1958 (66 yo M) <span class="bold">Acc No.</span> 10361 <span class="bold">DOS:</span> 08/26/2024</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>GIBBS, Lyndall C<br/><span class="bold">Account Number: </span>10361</td><td align="right"><span class="bold">Provider: </span>Faiza Tahir, MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>03/06/1958<span class="bold">   Age: </span>66 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>08/26/2024</td></tr><tr><td><span class="bold">Phone: </span>559-309-9335</td></tr><tr><td colspan="2"><span class="bold">Address: </span>10426 BRAEMER ST, CROSBY, TX-77532-7009</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   2 month f/u</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">follow up</span>: <br/>       65 year old male with PMH of COPD, CHF, aortic insufficiency s/p TAVR, hx of infective endocarditis on chronic suppressive antibiotics presents to ID clinic for evaluation of possible histoplasmosis. Patient was admitted to hospital for encephalopathy and possible CVA. As per medical records MRI brain revealed punctate L frontal infarct of cryptogenic etiology, possible cardioembolic in nature. Patient also reported history fever, weight loss, comprehensive infectious diseases workup including HIV, TB were negative however patient was found to have positive urine and serum histoplama antigens raising concern for dessiminated histoplasmosis, patient was started on amphoteracin B, completed 2 weeks course followed by transition to fluconazole by ID physician at rehab facility. Patient is currently taking fluconazole 800mg daily, denies fever/chills, night sweats, overall feels clinically improving, denies headache, worsening cough, dyspnea, chest pain, nausea/vomiting, abd pain, or any genitourinary symptoms.<br/><br/>Interval Hx 9/28/2023:<br/>Patient w/ disseminated histoplasmosis presents for follow up. Patient is doing well, continues to have issue w/ short term memory, otherwise denies headache, neck pain/stiffness, visual problems, also denies cough, dyspnea, chest pain, no nausea/vomiting, diarrhea, fever/chills, night sweats, weight loss, tolerating fluconazole well.<br/><br/>Interval Hx 10/17/2023:<br/>Patient presents for follow up, doing well, no changes since last visit, mentation issues improving gradually, no active complaints, reports occasional cough however dry, no dyspnea, chest pain, headache, fever/chills, night sweats, lower extremity swelling, tolerating fluconazole well, no nausea/vomiting, RUQ pain, jaundice.<br/><br/>Intervla Hx 11/03/2023:<br/>Patient doing well, reports some cough early in the morning, however no worsening dyspnea, night sweats, persistent low appetite however no longer loosing weight, denies fever/chills, nausea/vomiting. Patient still in process to having his valve replacement, getting both his mitral and aortic valve replaced possibly w/ bovine valves in near future, waiting on dental clearance.<br/><br/>Interval Hx 11/16/2023:<br/>Patient presents for follow up, doing well, reports energy level is better, appetite also better, eating and drinking well, no longer loosing weight, denies cough, dyspnea, chest pain, fever/chills, night sweats, tolerating fluconazole well. Patient scheduled for open heart valve replacement on 11/29/2023.<br/><br/>Interval Hx 11/28/2023<br/>Patient presents for follow up to go over labs results, no new complaints, doing well, denies dyspnea, cough, night sweats, fever/chills, good appetite, tolerating fluconazole, no nausea/vomiting, RUQ pain.<br/><br/>Interval Hx 12/29/2023:<br/>Patient presents for follow up, doing well, underwent open heart surgery for valve replacement, recovering well, incision almost healed, reports some shortness of breath however denies worsening cough, dyspnea, chest pain, weight loss, fever/chills, night sweats, appetite is good, no nausea/vomiting, abd pain, diarrhea, headache, confusion or visual/hearing problems. Tolerating fluconazole, no RUQ pain.<br/><br/>Interval Hx 2/15/2024:<br/>Patient presents for follow up, doing well, no new complaints, persistent cough, however unchanged, no worsening dyspnea, chest pain, night sweats, weight loss, fever/chills, headache, nausea/vomiting, abd pain, tolerating fluconazole well.<br/>04/22/24<br/>pt reports cough is better is not as presistent as before. pt states he is doing better now. no complains or concerns at this time.<br/>06/25/24<br/>pt here f/u for persistent cough. pt states he has not cough as much as before. pt continues on oral abx. pt has no other concerns at this time.<br/>08/26/24<br/>pt f/u for persistant cough. pt states that his cough is good now. he is still taking oral abx.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   A 14-point review of systems is otherwise negative.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> Bronchoscopy </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> methodist </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="content_span">Denies smoking, alcohol, recreational drug use</span>.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingCephalexin 500 MG Capsule 1 capsule Orally Four times a day Fluconazole 200 MG Tablet 2 tablet Orally daily Omega 3      Potassimin      Magnesium      Omeprazole      Lisinopril      Furosemide      Finasteride      Ferrous Sulfate      Aspirin      Cephalexin 500 MG Capsule 1 capsule Orally Twice a day Taking Cephalexin 500 MG Capsule 1 capsule Orally Four times a day Taking Fluconazole 200 MG Tablet 2 tablet Orally daily Taking Omega 3      Taking Potassimin      Taking Magnesium      Taking Omeprazole      Taking Lisinopril      Taking Furosemide      Taking Finasteride      Taking Ferrous Sulfate      Taking Aspirin      Taking Cephalexin 500 MG Capsule 1 capsule Orally Twice a day </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> BP: <span class="bold">122/73</span> mm Hg, HR: <span class="bold">70</span> /min, RR: <span class="bold">18</span> /min, Temp: <span class="bold">97.4</span> F, Oxygen sat %: <span class="bold">97</span> %.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="bold">   Past Orders:</span></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:HEPATITIS PANEL, GENERAL (6462) (Order Date - 06/25/2024) (Collection Date &amp; Time - 06/25/2024 03:41 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        HEPATITIS A AB, TOTAL</td><td align="left">REACTIVE</td><td align="left">A</td><td align="left">NON-REACTIVE - </td></tr><tr><td align="left">        HEPATITIS B SURFACE ANTIBODY QL</td><td align="left">NON-REACTIVE</td><td align="left"/><td align="left">NON-REACTIVE - </td></tr><tr><td align="left">        HEPATITIS B CORE AB TOTAL</td><td align="left">NON-REACTIVE</td><td align="left"/><td align="left">NON-REACTIVE - </td></tr><tr><td align="left">        HEPATITIS B SURFACE ANTIGEN</td><td align="left">NON-REACTIVE</td><td align="left"/><td align="left">NON-REACTIVE - </td></tr><tr><td align="left">        HEPATITIS C ANTIBODY</td><td align="left">NON-REACTIVE</td><td align="left"/><td align="left">NON-REACTIVE - </td></tr><tr><td colspan="4"><span class="content_span">        Notes: Tahir, Faiza 06/27/2024 02:27:51 PM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:HIV 1/2 ANTIGEN/ANTIBODY,FOURTH GENERATION W/RFL (91431) (Order Date - 06/25/2024) (Collection Date &amp; Time - 06/25/2024 03:41 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        HIV AG/AB, 4TH GEN</td><td align="left">REPEATEDLY REACTIVE</td><td align="left">A</td><td align="left">NON-REACTIVE - </td></tr><tr><td align="left">        HIV 1 ANTIBODY</td><td align="left">NEGATIVE</td><td align="left"/><td align="left">NEGATIVE - </td></tr><tr><td align="left">        HIV 2 ANTIBODY</td><td align="left">NEGATIVE</td><td align="left"/><td align="left">NEGATIVE - </td></tr><tr><td colspan="4"><span class="content_span">        Notes: Tahir, Faiza 06/27/2024 02:27:51 PM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:COMPREHENSIVE METABOLIC PANEL (10231)</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">06/25/2024</td><td align="left">04/22/2024</td><td align="left">02/15/2024</td><td align="left">11/03/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">03:41 PM</td><td align="left">04:13 PM</td><td align="left">02:12 PM</td><td align="left">11:00 AM</td></tr><tr><td align="left">Order Date</td><td align="left">06/25/2024</td><td align="left">04/22/2024</td><td align="left">02/15/2024</td><td align="left">11/03/2023</td></tr><tr><td align="left">GLUCOSE</td><td align="left">94<br/>(Ref Range: 65-99 mg/dL)</td><td class="bold" align="left">114    H<br/>(Ref Range: 65-99 mg/dL)</td><td class="bold" align="left">105    H<br/>(Ref Range: 65-99 mg/dL)</td><td class="bold" align="left">53    L<br/>(Ref Range: 65-139 mg/dL)</td></tr><tr><td align="left">UREA NITROGEN (BUN)</td><td align="left">23<br/>(Ref Range: 7-25 mg/dL)</td><td align="left">24<br/>(Ref Range: 7-25 mg/dL)</td><td class="bold" align="left">27    H<br/>(Ref Range: 7-25 mg/dL)</td><td align="left">20<br/>(Ref Range: 7-25 mg/dL)</td></tr><tr><td align="left">CREATININE</td><td align="left">0.95<br/>(Ref Range: 0.70-1.35 mg/dL)</td><td align="left">1.16<br/>(Ref Range: 0.70-1.35 mg/dL)</td><td align="left">1.27<br/>(Ref Range: 0.70-1.35 mg/dL)</td><td align="left">1.31<br/>(Ref Range: 0.70-1.35 mg/dL)</td></tr><tr><td align="left">BUN/CREATININE RATIO</td><td align="left">SEE NOTE:<br/>(Ref Range: 6-22 (calc))</td><td align="left">SEE NOTE:<br/>(Ref Range: 6-22 (calc))</td><td align="left">21<br/>(Ref Range: 6-22 (calc))</td><td align="left">SEE NOTE:<br/>(Ref Range: 6-22 (calc))</td></tr><tr><td align="left">SODIUM</td><td align="left">140<br/>(Ref Range: 135-146 mmol/L)</td><td align="left">138<br/>(Ref Range: 135-146 mmol/L)</td><td align="left">138<br/>(Ref Range: 135-146 mmol/L)</td><td align="left">138<br/>(Ref Range: 135-146 mmol/L)</td></tr><tr><td align="left">POTASSIUM</td><td align="left">4.5<br/>(Ref Range: 3.5-5.3 mmol/L)</td><td align="left">4.2<br/>(Ref Range: 3.5-5.3 mmol/L)</td><td align="left">4.2<br/>(Ref Range: 3.5-5.3 mmol/L)</td><td align="left">4.1<br/>(Ref Range: 3.5-5.3 mmol/L)</td></tr><tr><td align="left">CHLORIDE</td><td align="left">108<br/>(Ref Range: 98-110 mmol/L)</td><td align="left">104<br/>(Ref Range: 98-110 mmol/L)</td><td align="left">105<br/>(Ref Range: 98-110 mmol/L)</td><td align="left">102<br/>(Ref Range: 98-110 mmol/L)</td></tr><tr><td align="left">CARBON DIOXIDE</td><td align="left">24<br/>(Ref Range: 20-32 mmol/L)</td><td align="left">24<br/>(Ref Range: 20-32 mmol/L)</td><td align="left">26<br/>(Ref Range: 20-32 mmol/L)</td><td align="left">24<br/>(Ref Range: 20-32 mmol/L)</td></tr><tr><td align="left">CALCIUM</td><td align="left">10.1<br/>(Ref Range: 8.6-10.3 mg/dL)</td><td align="left">10.1<br/>(Ref Range: 8.6-10.3 mg/dL)</td><td align="left">9.4<br/>(Ref Range: 8.6-10.3 mg/dL)</td><td class="bold" align="left">10.4    H<br/>(Ref Range: 8.6-10.3 mg/dL)</td></tr><tr><td align="left">PROTEIN, TOTAL</td><td align="left">6.6<br/>(Ref Range: 6.1-8.1 g/dL)</td><td align="left">6.5<br/>(Ref Range: 6.1-8.1 g/dL)</td><td align="left">6.5<br/>(Ref Range: 6.1-8.1 g/dL)</td><td align="left">6.2<br/>(Ref Range: 6.1-8.1 g/dL)</td></tr><tr><td align="left">ALBUMIN</td><td align="left">4.1<br/>(Ref Range: 3.6-5.1 g/dL)</td><td align="left">3.8<br/>(Ref Range: 3.6-5.1 g/dL)</td><td align="left">3.9<br/>(Ref Range: 3.6-5.1 g/dL)</td><td align="left">3.6<br/>(Ref Range: 3.6-5.1 g/dL)</td></tr><tr><td align="left">GLOBULIN</td><td align="left">2.5<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td><td align="left">2.7<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td><td align="left">2.6<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td><td align="left">2.6<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td></tr><tr><td align="left">ALBUMIN/GLOBULIN RATIO</td><td align="left">1.6<br/>(Ref Range: 1.0-2.5 (calc))</td><td align="left">1.4<br/>(Ref Range: 1.0-2.5 (calc))</td><td align="left">1.5<br/>(Ref Range: 1.0-2.5 (calc))</td><td align="left">1.4<br/>(Ref Range: 1.0-2.5 (calc))</td></tr><tr><td align="left">BILIRUBIN, TOTAL</td><td align="left">0.4<br/>(Ref Range: 0.2-1.2 mg/dL)</td><td align="left">0.5<br/>(Ref Range: 0.2-1.2 mg/dL)</td><td align="left">0.4<br/>(Ref Range: 0.2-1.2 mg/dL)</td><td align="left">0.4<br/>(Ref Range: 0.2-1.2 mg/dL)</td></tr><tr><td align="left">ALKALINE PHOSPHATASE</td><td align="left">72<br/>(Ref Range: 35-144 U/L)</td><td align="left">86<br/>(Ref Range: 35-144 U/L)</td><td align="left">73<br/>(Ref Range: 35-144 U/L)</td><td align="left">107<br/>(Ref Range: 35-144 U/L)</td></tr><tr><td align="left">AST</td><td align="left">15<br/>(Ref Range: 10-35 U/L)</td><td align="left">14<br/>(Ref Range: 10-35 U/L)</td><td align="left">16<br/>(Ref Range: 10-35 U/L)</td><td align="left">14<br/>(Ref Range: 10-35 U/L)</td></tr><tr><td align="left">ALT</td><td class="bold" align="left">7    L<br/>(Ref Range: 9-46 U/L)</td><td class="bold" align="left">6    L<br/>(Ref Range: 9-46 U/L)</td><td align="left">10<br/>(Ref Range: 9-46 U/L)</td><td class="bold" align="left">5    L<br/>(Ref Range: 9-46 U/L)</td></tr><tr><td align="left">EGFR</td><td align="left">88<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td><td align="left">69<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td><td align="left">63<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td><td align="left">60<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td></tr><tr><td align="left">Notes:</td><td align="left">Tahir, Faiza 06/27/2024 02:27:51 PM &gt;</td><td align="left">Tahir, Faiza 04/27/2024 10:29:42 PM &gt;</td><td align="left">Tahir, Faiza 04/22/2024 03:13:06 PM &gt;</td><td align="left">Tahir, Faiza 11/7/2023 09:16:37 AM &gt; Tell patient labs are normal</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:CREATINE KINASE, TOTAL (374) (Order Date - 06/25/2024) (Collection Date &amp; Time - 06/25/2024 03:41 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        CREATINE KINASE, TOTAL</td><td align="left">47</td><td align="left"/><td align="left">44-196 - U/L</td></tr><tr><td colspan="4"><span class="content_span">        Notes: Tahir, Faiza 06/27/2024 02:27:51 PM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:CBC (H/H, RBC, INDICES, WBC, PLT) (1759)</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">06/25/2024</td><td align="left">04/22/2024</td><td align="left">02/15/2024</td></tr><tr><td align="left">Collection Time</td><td align="left">03:41 PM</td><td align="left">04:13 PM</td><td align="left">02:12 PM</td></tr><tr><td align="left">Order Date</td><td align="left">06/25/2024</td><td align="left">04/22/2024</td><td align="left">02/15/2024</td></tr><tr><td align="left">WHITE BLOOD CELL COUNT</td><td align="left">5.2<br/>(Ref Range: 3.8-10.8 Thousand/uL)</td><td align="left">8.4<br/>(Ref Range: 3.8-10.8 Thousand/uL)</td><td align="left">6.3<br/>(Ref Range: 3.8-10.8 Thousand/uL)</td></tr><tr><td align="left">RED BLOOD CELL COUNT</td><td class="bold" align="left">3.88    L<br/>(Ref Range: 4.20-5.80 Million/uL)</td><td class="bold" align="left">3.73    L<br/>(Ref Range: 4.20-5.80 Million/uL)</td><td class="bold" align="left">3.34    L<br/>(Ref Range: 4.20-5.80 Million/uL)</td></tr><tr><td align="left">HEMOGLOBIN</td><td class="bold" align="left">11.9    L<br/>(Ref Range: 13.2-17.1 g/dL)</td><td class="bold" align="left">11.2    L<br/>(Ref Range: 13.2-17.1 g/dL)</td><td class="bold" align="left">10.0    L<br/>(Ref Range: 13.2-17.1 g/dL)</td></tr><tr><td align="left">HEMATOCRIT</td><td class="bold" align="left">36.7    L<br/>(Ref Range: 38.5-50.0 %)</td><td class="bold" align="left">34.3    L<br/>(Ref Range: 38.5-50.0 %)</td><td class="bold" align="left">30.4    L<br/>(Ref Range: 38.5-50.0 %)</td></tr><tr><td align="left">MCV</td><td align="left">94.6<br/>(Ref Range: 80.0-100.0 fL)</td><td align="left">92.0<br/>(Ref Range: 80.0-100.0 fL)</td><td align="left">91.0<br/>(Ref Range: 80.0-100.0 fL)</td></tr><tr><td align="left">MCH</td><td align="left">30.7<br/>(Ref Range: 27.0-33.0 pg)</td><td align="left">30.0<br/>(Ref Range: 27.0-33.0 pg)</td><td align="left">29.9<br/>(Ref Range: 27.0-33.0 pg)</td></tr><tr><td align="left">MCHC</td><td align="left">32.4<br/>(Ref Range: 32.0-36.0 g/dL)</td><td align="left">32.7<br/>(Ref Range: 32.0-36.0 g/dL)</td><td align="left">32.9<br/>(Ref Range: 32.0-36.0 g/dL)</td></tr><tr><td align="left">RDW</td><td align="left">13.3<br/>(Ref Range: 11.0-15.0 %)</td><td align="left">13.3<br/>(Ref Range: 11.0-15.0 %)</td><td align="left">14.4<br/>(Ref Range: 11.0-15.0 %)</td></tr><tr><td align="left">PLATELET COUNT</td><td align="left">161<br/>(Ref Range: 140-400 Thousand/uL)</td><td align="left">246<br/>(Ref Range: 140-400 Thousand/uL)</td><td align="left">226<br/>(Ref Range: 140-400 Thousand/uL)</td></tr><tr><td align="left">MPV</td><td align="left">11.3<br/>(Ref Range: 7.5-12.5 fL)</td><td align="left">11.3<br/>(Ref Range: 7.5-12.5 fL)</td><td align="left">10.8<br/>(Ref Range: 7.5-12.5 fL)</td></tr><tr><td align="left">Notes:</td><td align="left">Tahir, Faiza 06/27/2024 02:27:51 PM &gt;</td><td align="left">Tahir, Faiza 04/27/2024 10:29:42 PM &gt;</td><td align="left">Tahir, Faiza 04/22/2024 03:13:06 PM &gt;</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:SED RATE BY MODIFIED WESTERGREN (809)</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">06/25/2024</td><td align="left">04/22/2024</td></tr><tr><td align="left">Collection Time</td><td align="left">03:41 PM</td><td align="left">04:13 PM</td></tr><tr><td align="left">Order Date</td><td align="left">06/25/2024</td><td align="left">04/22/2024</td></tr><tr><td align="left">SED RATE BY MODIFIED</td><td class="bold" align="left">29    H<br/>(Ref Range: &lt; OR = 20 mm/h)</td><td align="left">11<br/>(Ref Range: &lt; OR = 20 mm/h)</td></tr><tr><td align="left">Notes:</td><td align="left">Tahir, Faiza 06/27/2024 02:27:51 PM &gt;</td><td align="left">Tahir, Faiza 04/27/2024 10:29:42 PM &gt;</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:RPR (DX) W/REFL TITER AND CONFIRMATORY TESTING (36126) (Order Date - 06/25/2024) (Collection Date &amp; Time - 06/25/2024 03:41 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        RPR (DX) W/REFL TITER AND</td><td align="left">NON-REACTIVE</td><td align="left"/><td align="left">NON-REACTIVE - </td></tr><tr><td colspan="4"><span class="content_span">        Notes: Tahir, Faiza 06/27/2024 02:27:51 PM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:C-REACTIVE PROTEIN (4420)</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">06/25/2024</td><td align="left">04/22/2024</td></tr><tr><td align="left">Collection Time</td><td align="left">03:41 PM</td><td align="left">04:13 PM</td></tr><tr><td align="left">Order Date</td><td align="left">06/25/2024</td><td align="left">04/22/2024</td></tr><tr><td align="left">C-REACTIVE PROTEIN</td><td class="bold" align="left">27.8    H<br/>(Ref Range: &lt;8.0 mg/L)</td><td class="bold" align="left">66.5    H<br/>(Ref Range: &lt;8.0 mg/L)</td></tr><tr><td align="left">Notes:</td><td align="left">Tahir, Faiza 06/27/2024 02:27:51 PM &gt;</td><td align="left">Tahir, Faiza 04/27/2024 10:29:42 PM &gt;</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:COCCIDIOIDES AB(IGG,IGM), IMMUNODIFFUSION (19963) (Order Date - 06/25/2024) (Collection Date &amp; Time - 06/25/2024 03:41 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        AB TO TP ANTIGEN(IGM), ID</td><td align="left">NEGATIVE</td><td align="left"/><td align="left"> - </td></tr><tr><td align="left">        AB TO F ANTIGEN (IGG), ID</td><td align="left">NEGATIVE</td><td align="left"/><td align="left"> - </td></tr><tr><td colspan="4"><span class="content_span">        Notes: Tahir, Faiza 06/27/2024 02:27:51 PM &gt;  Tahir, Faiza 07/01/2024 09:58:34 AM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:HIV 1 RNA, QL REAL TIME PCR (16185) (Order Date - 06/25/2024) (Collection Date &amp; Time - 06/25/2024 03:41 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        HIV 1 RNA, QL REAL TIME</td><td align="left">Not Detected</td><td align="left"/><td align="left">Not Detected - </td></tr><tr><td colspan="4"><span class="content_span">        Notes: eclinicalworks, support 06/27/2024 11:10:14 : This order was created by the Interface.  Tahir, Faiza 06/27/2024 02:27:51 PM &gt;  Tahir, Faiza 07/01/2024 09:58:34 AM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:HISTOPLASMA CAPSULATUM DNA, REAL TIME PCR (90249) (Order Date - 06/25/2024) (Collection Date &amp; Time - 06/25/2024 03:41 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        HISTOPLASMA CAPSULATUM</td><td align="left">NOT DETECTED</td><td align="left"/><td align="left"> - </td></tr><tr><td align="left">        SOURCE</td><td align="left">WHOLE BLOOD</td><td align="left"/><td align="left"> - </td></tr><tr><td colspan="4"><span class="content_span">        Notes: Tahir, Faiza 06/27/2024 02:27:51 PM &gt;  Tahir, Faiza 07/01/2024 09:58:34 AM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:QUANTIFERON(R)-TB GOLD PLUS, 1 TUBE (36970) (Order Date - 06/25/2024) (Collection Date &amp; Time - 06/25/2024 03:41 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        QUANTIFERON(R)-TB GOLD</td><td align="left">NEGATIVE</td><td align="left"/><td align="left">NEGATIVE - </td></tr><tr><td align="left">        NIL</td><td align="left">0.01</td><td align="left"/><td align="left"> - IU/mL</td></tr><tr><td align="left">        MITOGEN-NIL</td><td align="left">&gt;10.00</td><td align="left"/><td align="left"> - IU/mL</td></tr><tr><td align="left">        TB1-NIL</td><td align="left">0.01</td><td align="left"/><td align="left"> - IU/mL</td></tr><tr><td align="left">        TB2-NIL</td><td align="left">0.01</td><td align="left"/><td align="left"> - IU/mL</td></tr><tr><td colspan="4"><span class="content_span">        Notes: Tahir, Faiza 06/27/2024 02:27:51 PM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Physical Examination:</span> <br/>   GEN: NAD.<br/>HEENT: NC/AT; MMM. <br/>CV: RRR<br/>LUNGS: CTAB, no w/r/c.<br/>ABD: Soft, NT/ND, <br/>SKIN: Warm, well perfused. No skin rashes or abnormal lesions.<br/>MSK: Normal gait. No deformities.<br/>EXT: No clubbing, cyanosis, or edema.<br/>NEURO: Ambulating with no limitations. No focal deficits.</td></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. HIV positive - Z21 (Primary)   2. Histoplasmosis, unspecified - B39.9   3. Chronic systolic (congestive) heart failure - I50.22   4. Endocarditis, valve unspecified - I38   5. Chronic obstructive pulmonary disease, unspecified - J44.9   6. Acute and subacute infective endocarditis - I33.0   7. Antibiotic long-term use - V58.62   8. Screening for STD (sexually transmitted disease) - Z11.3   9. HIV exposure - Z20.6   </td></tr><tr><td>#Dessiminated histoplasmosis:<br/>-patient w/ reported history of fever, weight loss, fatigue, limited records from hospitalization available at this point, no labratory or cultures data, however noted to have positive serum and urine hisotplasma antigens, s/p 2 weeks of amphotericin followed by transition to high dose fluconazole, currently tolerating well, patient's hospital records reviewed, LVEF 50-55% on latest TTE 5/2023, discussed w/ patient regarding switching to itraconazole as fluconzole has not shown to be as effective and could potentially have increased chances of recurrence later on, however patient currently undergoing evaluation for possible TAVR, w/ plan for surgery within the next month, patient/wife would like to hold off on switching to itraconzole for now pending decision regarding valve replacement especially considering multiple drug ineraction associated w/ itraconzole which will require close monitoring, patient might be started on anticoagulation post valve replacement surgery, latest serum/urine histo Ag trending down (urine Ag 6.58 0.4, serum Ag 1.751.01  0.35), will cont fluconzole, which is approved for use in patient who are not able to take itraconazole although it might not be as effective. Monitor patient closely clinically as well as close monitoring of serum/urine histoplasma antigens to assess response to therapy<br/><br/>#Hx of strep mitis IE and PJI:<br/>-on chronic supressive cephalexin</td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. HIV positive</span> <br/>     <span class="Underline">LAB: HIV 1/2 ANTIGEN/ANTIBODY,FOURTH GENERATION W/RFL (91431)</span><br/>     <span class="Underline">LAB: RPR (DX) W/REFL TITER AND CONFIRMATORY TESTING (36126)</span><br/>     <span class="Underline">LAB: LYMPHOCYTE SUBSET PANEL 5 (8360)</span><br/>     <span class="Underline">LAB: HIV 1 RNA, QL REAL TIME PCR (16185)</span><br/>     <span class="Underline">LAB: QUANTIFERON(R)-TB GOLD PLUS, 1 TUBE (36970)</span><br/>Notes:  Tahir, Faiza 08/26/2024 03:47:42 PM &gt; Patient has HIV test antigen antibody positive on 6/25/2024Last HIV antigen and antibody was checked on August 2023 which was negative patient denies any new sexual encounters or new sexual partners he is married for the past 15 years wife according to him is HIV negativeCheck CD4 count, viral load, and repeat HIV antigen antibody testingPatient will return to clinic in 2 weeks  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Histoplasmosis, unspecified</span> <br/>Notes: 4/22/24<br/>-Check serum histo Ag, CBC, CMP<br/>-Cont fluconzole 400mg daily, anticipate ~12 month course total<br/>-Cont cephalexcin for chronic supression indefinately<br/>-RTC 2 months <br/><br/>6/25/24<br/>cough improving <br/>c/w Fluconazole 200 mg bid <br/>check cbc,cmp,Rp,SED rate <br/>check serum histoplasma antigen and antibody  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Others </span> <br/>Refill Cephalexin Capsule, 500 MG, 1 capsule, Orally, Four times a day, 30 days, 120 Capsule, Refills 2; Refill Fluconazole Tablet, 200 MG, 2 tablet, Orally, daily, 30 days, 60 Tablet, Refills 2.  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 36410 VENIPUNCT, NON-ROUT*</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 2 Weeks (Reason: follow up)</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>36410 VENIPUNCT, NON-ROUT*. </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by Faiza Tahir , MD  on 08/26/2024 at 03:48 PM CDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> Faiza Tahir, MD</td><td align="right"><span class="bold">Date: </span>08/26/2024</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: 09/06/2024 01:44 PM CDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><br/><br/></body></html>